Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository

[1]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[2]  P. Lakatos,et al.  Smoking in inflammatory bowel diseases: good, bad or ugly? , 2007, World journal of gastroenterology.

[3]  Philip Rosenstiel,et al.  Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci , 2007, Proceedings of the National Academy of Sciences.

[4]  Judy H. Cho,et al.  Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC) , 2007, Inflammatory bowel diseases.

[5]  Judy H. Cho,et al.  Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People , 2007, The American Journal of Gastroenterology.

[6]  Judy H. Cho,et al.  Smoking and inflammatory bowel disease: Trends in familial and sporadic cohorts , 2007, Inflammatory bowel diseases.

[7]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[8]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[9]  Judy H. Cho,et al.  Inflammatory Bowel Disease Characteristics Among African Americans, Hispanics, and Non-Hispanic Whites: Characterization of a Large North American Cohort , 2006, The American Journal of Gastroenterology.

[10]  P. Rutgeerts,et al.  Current status of genetics research in inflammatory bowel disease , 2005, Genes and Immunity.

[11]  B. Brais,et al.  Population history and its impact on medical genetics in Quebec , 2005, Clinical genetics.

[12]  Dhiman Basu,et al.  Impact of Race and Ethnicity on Inflammatory Bowel Disease , 2005, The American Journal of Gastroenterology.

[13]  Xiaofeng Zhu,et al.  Genetic Structure, Self-identified Race/ethnicity, and Confounding in Case-control Association Studies , 2022 .

[14]  A. Andriulli,et al.  Variants of CARD15 are Associated with an Aggressive Clinical Course of Crohn's Disease—An IG-IBD Study , 2005, The American Journal of Gastroenterology.

[15]  C. Gasche,et al.  Genotypes and phenotypes in Crohn’s disease: do they help in clinical management? , 2004, Gut.

[16]  J. Ioannidis,et al.  Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis , 2004, The American Journal of Gastroenterology.

[17]  Samir A. Shah,et al.  Ocular Manifestations of Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[18]  B. Avidan,et al.  Clinical and Demographic Characterization of Jewish Crohn's Disease Patients in Israel , 2003, Journal of clinical gastroenterology.

[19]  M. Daly,et al.  CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. , 2002, American journal of human genetics.

[20]  C. O'Morain,et al.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. , 2002, American journal of human genetics.

[21]  T. Ahmad,et al.  The molecular classification of the clinical manifestations of Crohn's disease. , 2002, Gastroenterology.

[22]  T. Judge,et al.  Extraintestinal manifestations of inflammatory bowel disease. , 2002, Gastroenterology clinics of North America.

[23]  H. Freeman.  Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. , 2001, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[24]  M. Kogevinas,et al.  Clinical Patterns of Crohn’s Disease in Greece: A Follow-Up Study of 155 Cases , 2000, Digestion.

[25]  D. Jewell,et al.  A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.

[26]  R. Sandler,et al.  Crohn's disease: does race matter? , 2000, American Journal of Gastroenterology.

[27]  M. Braekeleer,et al.  Hereditary disorders in the French Canadian population of Quebec. I. In search of founders. , 1994, Human biology.

[28]  G. Brunet.  G. Bouchard et M. De Braekeleer (SOUS la direction de), Histoire d'un génome, Laval, Presses de l'Université du Québec, 1991, 607 p. , 1991, Annales: Histoire, Sciences Sociales.

[29]  B. Calkins.  A meta-analysis of the role of smoking in inflammatory bowel disease , 1989, Digestive diseases and sciences.

[30]  Beverly M. Calkins DHSc.  A meta-analysis of the role of smoking in inflammatory bowel disease , 2005, Digestive Diseases and Sciences.

[31]  S. Targan,et al.  Mutations in NOD 2 Are Associated With Fibrostenosing Disease in Patients With Crohn ’ s Disease , 2002 .

[32]  H. Freeman,et al.  Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients. , 2001, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[33]  W. Murphy,et al.  The French founders of North America and their heritage , 1976 .

[34]  G. Rogler,et al.  Extraintestinal Manifestations of In fl ammatory Bowel Disease , 2022 .